The impact of treatment with levodopa on Parkinson's disease.
about
Mortality in levodopa-treated Parkinson's disease.Spinal cord stimulation restores locomotion in animal models of Parkinson's diseaseA comparison of the effects of controlled-release levodopa (Madopar CR) with conventional levodopa in late Parkinson's diseaseSpinal cord stimulation in the United KingdomThe pre-morbid personality of patients with Parkinson's disease.The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.The on-off phenomenonTreatment of Depression in the Patient with Parkinson's Disease.Motor response to levodopa in patients with parkinsonian motor fluctuations: a follow-up study over three years.The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations.The sydney multicentre study of Parkinson's disease: progression and mortality at 10 yearsComparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United KingdomAdrenal and nigral transplants for Parkinson's disease.The motor response to sequential apomorphine in parkinsonian fluctuations.Speech disorders of Parkinsonism: a review.A controlled study of dementia in Parkinson's diseaseSubcutaneous apomorphine infusion in Parkinson's disease: does it have a role?Depression in Parkinson's disease. Pharmacological characteristics and treatment.Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.Gastric emptying in healthy volunteers after multiple doses of levodopa.Levodopa: long-term impact on Parkinson's disease.Drug treatment in Parkinson's disease.Levodopa: long-term impact on Parkinson's disease.Adjunct rasagiline to treat Parkinson’s disease with motor fluctuations: a randomized, double-blind study in China.
P2860
Q30414368-F7C9CFD5-EE56-430C-9DAC-6A5C9F30EC51Q30487075-0D63FFE6-CE16-4E3E-98AA-853A85459F2CQ33588725-7D2E11DD-2FEA-47AC-8261-5ED1AE902F18Q33618592-9BC36769-B46A-42D6-9678-F70F6EB1C93FQ33620681-A6364ED9-EBB3-4440-983D-5031D9402DBAQ33629388-619FE7C9-6CDF-4FB9-9CBD-983C0FCA832FQ33631685-306015B3-F34A-4F06-BD93-95585666ACF8Q33704127-5D5FD24D-FCBB-4BBE-8293-2B36571C3706Q33732338-9CA974C3-3E87-4DCB-B66B-6AD849482825Q33732870-1C4854E8-6B8A-4EC4-BFB9-5E0E4CDFAC0DQ34448102-A33152F2-DCD9-4CB4-B8E5-E47A170B0E2EQ35452958-C2A8498B-2B44-4254-AE51-D5EC0A53175DQ36790493-812752F5-6669-4EAC-A7B0-C37C8CB4B998Q36895972-984096C1-97DD-423E-943E-838E078FC4CBQ36946530-C5E767C2-55F1-4FAB-8827-39DB5FB836F7Q37014233-10EB8CB1-641A-44A6-BFEA-B4AC279FFAD4Q37027133-BE10FD81-3D96-4B6E-A192-5442656DB0C8Q38632707-5913DA07-C083-413C-9217-BC9BDE2D502CQ39450868-996398F0-DA30-44A9-A2B1-DA3139ABA00EQ41591036-C4798FF1-FA43-4950-9C74-A1B737808FE7Q42031336-3C74470A-C26A-4FCC-9D71-9F9CB3401486Q42347426-B26BAA96-AD7E-4976-B86A-D5CCB5C65CC1Q43061040-2659C339-772B-4690-97C4-60A5C546D3EBQ45336203-EE497424-CD00-4271-A2B4-F3C5F07AD168Q55516146-1AA590DA-7A21-436E-B84F-D84BC5EF6E0D
P2860
The impact of treatment with levodopa on Parkinson's disease.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
The impact of treatment with levodopa on Parkinson's disease.
@en
The impact of treatment with levodopa on Parkinson's disease.
@nl
type
label
The impact of treatment with levodopa on Parkinson's disease.
@en
The impact of treatment with levodopa on Parkinson's disease.
@nl
prefLabel
The impact of treatment with levodopa on Parkinson's disease.
@en
The impact of treatment with levodopa on Parkinson's disease.
@nl
P2093
P1476
The impact of treatment with levodopa on Parkinson's disease
@en
P2093
P304
P577
1980-01-01T00:00:00Z